Brain (and spinal cord) tumours
Results
Phase 2
This trial combined bevacizumab (Avastin) with temozolomide (Temodal) for a type of brain tumour called a grade 2 or 3 glioma.
It was for people whose glioma had come back after treatment
Recruitment start: 29 August 2011
Recruitment end: 10 July 2015
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Sara Erridge
European Organisation for Research and Treatment of Cancer (EORTC)
Experimental Cancer Medicine Centre (ECMC)
F.Hoffmann-La Roche Ltd (Roche)
NIHR Clinical Research Network: Cancer
Last reviewed: 22 May 2019
CRUK internal database number: 8995
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
